| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.900 | 10 | 0 | 1993 | 2019 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2019 | |||||||||
|
ABRA C-terminal like | 0.931 | 0.077 | 0.24 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
abraxas 2, BRISC complex subunit | 0.760 | 0.308 | 2.0E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
acetyl-CoA carboxylase alpha | 0.480 | 0.846 | 1.00 |
|
phenotype | 0.060 | None | 0.833 | 6 | 0 | 2009 | 2019 | ||||||||
|
acyl-CoA dehydrogenase family member 8 | 0.506 | 0.885 | 5.6E-14 |
|
phenotype | 0.070 | None | 1.000 | 7 | 0 | 2009 | 2018 | ||||||||
|
acyl-CoA dehydrogenase medium chain | 0.638 | 0.462 | 2.1E-12 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
acetyl-CoA acetyltransferase 1 | 0.538 | 0.692 | 9.9E-08 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2010 | 2020 | ||||||||
|
acyl-CoA binding domain containing 3 | 0.805 | 0.385 | 1.1E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
phenotype | 0.080 | None | 0.750 | 8 | 1 | 1996 | 2017 | ||||||||
|
Asymmetric crying facies (Cayler cardiofacial syndrome) | 0.729 | 0.462 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2017 | |||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
atypical chemokine receptor 2 | 0.641 | 0.615 | 1.4E-03 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | ||||||||
|
atypical chemokine receptor 3 | 0.428 | 0.885 | 0.39 |
|
phenotype | 0.100 | None | 0.952 | 21 | 0 | 2007 | 2019 | ||||||||
|
ATP citrate lyase | 0.563 | 0.692 | 8.4E-02 |
|
phenotype | 0.050 | None | 1.000 | 5 | 0 | 2012 | 2019 | ||||||||
|
aconitase 2 | 0.619 | 0.654 | 0.21 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
aconitate decarboxylase 1 | 0.861 | 0.154 | 4.6E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
acyl-CoA oxidase 1 | 0.610 | 0.731 | 6.2E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
acid phosphatase 2, lysosomal | 0.780 | 0.346 | 6.2E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
acid phosphatase 3 | 0.525 | 0.731 | 2.5E-16 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
acid phosphatase 5, tartrate resistant | 0.561 | 0.731 | 7.9E-02 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
acrosin | 0.493 | 0.846 | 1.2E-02 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 1980 | 2019 | ||||||||
|
acrosin binding protein | 0.705 | 0.308 | 2.7E-10 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
acyl-CoA synthetase long chain family member 1 | 0.617 | 0.577 | 1.5E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |